2008

• Central Nervous System Metastases in HER-2—Overexpressing Metastatic Breast Cancer: A Treatment Challenge
• The CYP19 TTTA Repeat Polymorphism Is Related to the Prognosis of Premenopausal Stage I—II and Operable Stage III Breast Cancers
• Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
• Should Urogenital Atrophy in Breast Cancer Survivors Be Treated With Topical Estrogens?
• Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor—Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole
• Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer
• Use of i.v. Bisphosphonates in Older Women with Breast Cancer
• Targeted Therapies for the Treatment of Breast Cancer in the Post-trastuzumab Era
• Current Status of Prognostic Profiling in Breast Cancer EXPIRED
• Ixabepilone: A Novel Antineoplastic Agent with Low Susceptibility to Multiple Tumor Resistance Mechanisms
• Prognostic Value of Initial Clinical Disease Stage After Achieving Pathological Complete Response